BioSpace News Archive

FDA

Nevro Wins FDA OK for Senza II Spinal Cord Stimulation System Delivering HF10 Therapy

The Senza II system offers the superior outcomes and clinical advantages of HF10 therapy through a smaller and more refined footprint while maintaining the performance and durability of the current IPG.

January 8, 2018
·
2 min read
Business

QIAGEN and DiaSorin Partner to Offer Fully Automated Tuberculosis Detection With QuantiFERON-TB Gold Plus Available on LIAISON Analyzer Systems

This addition will enable customers of both companies to process QuantiFERON-TB Gold Plus on LIAISON family platforms.

January 8, 2018
·
2 min read
Drug Development

TopiVert Pharma Limited: Positive Results From TOP1288 Phase I Study

TopiVert announces positive data from its Phase 1 study (TV03) with its oral formulation of TOP1288 for the treatment of ulcerative colitis (UC).

January 8, 2018
·
6 min read
Business

sterna biologicals Appoints Christian Pangratz as Chief Executive Officer

He brings over 25 years of life sciences experience, notably in the areas of strategic planning, corporate and business development, alliance and project management, new product planning, marketing and sales.

January 8, 2018
·
3 min read
Business

Mazor Robotics Received 27 System Orders During Q4 2017; Expects to Report Record Full Year and Quarterly Revenue

Mazor Robotics expects to report record revenue of approximately $65M for the full year ended December 31, 2017.

January 8, 2018
·
5 min read
Business

Acerus Enters into a Licensing Agreement with Innovus to Commercialize UriVarx® in Canada

Under the terms of the exclusive distributor and license agreement, Innovus will receive a payment at signing, as well as milestone payments based on Acerus achieving certain sales targets.

January 8, 2018
·
5 min read
Genetown

Medicare Part D (Prescription Drug) Plans May Now Cover Omnipod

Insulet today announced that the Centers for Medicare and Medicaid Services (CMS) has issued guidance clarifying that Medicare Part D Plan Sponsors may provide coverage for products such as the Omnipod System under the Medicare Part D (prescription drug) program.

January 8, 2018
·
5 min read
Business

TransEnterix Provides 2017 Year End Corporate Update

During the quarter ending December 31, 2017, the Company sold two Senhance Systems for total revenue of approximately $3.3 million.

January 8, 2018
·
5 min read
Pharm Country

Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available ‘Big Data’ Human Sequencing Resource With UK Biobank

Regeneron along with new collaborators AbbVie, Alnylam, AstraZeneca, Biogen and Pfizer, today announced the formation of a major ‘pre-competitive’ consortium to fund the generation of genetic exome sequence data from the 500,000 volunteer participants who make up the UK Biobank health resource.

January 8, 2018
·
13 min read
Neovasc Reports Tiara’s Clinical Case Load Accelerating

Neovasc today provided an update on its clinical program for the Tiara valve.

January 8, 2018
·
8 min read